Thevenot T, Elkrief L, Bureau C, Bardou-Jacquet E, et al. Effect of rifaximin in patients with severe cirrhosis and ascites: A randomized double-blind placebo-controlled clinical trial. J Hepatol 2025 Jul 11:S0168-8278(25)02318-9. doi: 10.1016/j.jhep.2025.
PMID: 40653111